Platelet-derived growth factor-B (PDGF-B) is important for normal tissue growth and maintenance and its overexpression has been linked to several diseases, including cancer, fibrotic disease and atherosclerosis. Here, we show that synthesized as a precursor, proPDGF-B is converted to a mature form by proteolytic cleavage at two sites and its N-terminal cleavage is a prerequisite for processing at its C-terminus. The first cleavage occurs at residues RGRR 
Introduction
Platelet-derived growth factor (PDGF) is a disulfidelinked dimer composed of two polypeptide chains, denoted A and B and represented in vivo by three PDGFs, PDGF-AA, PDGF-AB and PDGF-BB (Robbins et al., 1983; Heldin et al., 1986; Beckmann et al., 1988; Hart et al., 1990; Heldin and Westermark, 1999) . These isoforms bind to and activate two structurally related protein tyrosine kinase receptors, PDGFR-a and PDGFR-b. The a-receptor binds both the A and B chains of PDGF, but the b-receptor binds only the B chain. Recently, two new members of the PDGF family, PDGF-C and PDGF-D, were reported. PDGF-CC acts as a ligand for PDGFR-a (Li et al., 2000) and PDGF-DD as a ligand for PDGFR-b (Bergsten et al., 2001) . Following alternative splicing, the A-chain is expressed as two different isoforms, a longer and a shorter variant. The longer variant (241 amino acids, (aa)) is less common and differs from the shorter one (196 aa) by a C-terminal extension of 18 aa (Beckmann et al., 1988; Bywater et al., 1988; Ostman et al., 1992) . While the A chains are singly cleaved in the Golgi complex at the RRKR 86 k sequence (Siegfried et al., 2003b) to yield, predominantly, the secreted B30 kDa PDGF-AA products, it was reported that at least three forms of PDGF-BB can be formed. This includes an B24 kDa form retained intracellularly and degraded in lysosomes, a secreted B30 kDa form and an B40 kDa cell surface-associated form (Ostman et al., 1992) . Using various PDGF chimeras, LaRochelle et al. (1991) identified the C-terminal residues 212-226 of PDGF-B as the amino-acid sequence responsible for the retention properties of the surface-associated form of PDGF-B. The ratio of the various forms of PDGF-BB is likely to be dependent upon the activity of the proteases involved in PDGF-B processing. Analysis of the aa sequence of PDGF-B precursors revealed proprotein convertase (PC)-like cleavage motifs upstream and downstream of the residues constituting the N-terminus and C-terminus of the mature PDGF-B, suggesting the involvement of PCs in the cleavage of proPDGF-B at these sites (Khatib et al., 2002) .
The mammalian subtilisin-like PCs constitute a family of nine secretory serine proteineases, seven that are dibasic-specific, namely Furin, PC1, PC2, PC4, PACE4, PC5 and PC7 Khatib et al., 2002) , as well as the nonbasic specific convertases SKI-1 (Seidah and Prat, 2002) and NARC-1/PCSK9 . The basic aa-specific PCs are implicated in the processing of multiple protein precursors, including proteases, growth factors, and receptors at multibasic recognition sites exhibiting the general motif (K/R)-(X) n -(K/R)k (n ¼ 0, 2, 4 or 6) Benjannet et al., 2001; Khatib et al., 2002; Siegfried et al., 2003b) . The convertase SKI-1 recognizes the motif (R/K)-X-(L,V)-Zk, where Z is any aa except Pro, Cys, Glu, and Val (Seidah and Prat, 2002) , and NARC-1/PCSK9 recognizes the sequence VFAQk with Val at position P4 being critical (Benjannet et al., 2004) .
In this study, we demonstrated the implication of the basic aa-specific PCs in the N-terminal cleavage of proPDGF-B and the importance of these enzymes in the regulation of the processing of the B chain at the second C-terminal site that regulates the formation and the levels of the secreted and matrix-bound PDGF-BB forms.
Results

Processing of proPDGF-B
PDGF-B is a member of the PDGF/VEGF superfamily, where all the members require specific endoproteolytic cleavage for their activity. However, nothing is known about the enzyme(s) involved in the processing and activation of proPDGF-B. Following transient transfection of HK293 cells with a cDNA coding for wild-type PDGF-B, the PDGF-B specific polyclonal antibody detected in cell lysates three immunoreactive proteins migrating on SDS-PAGE as B35-, B24-and B15-17 kDa moieties ( Figure 1a ). To determine whether the B35 kDa protein detected is the proPDGF-B precursor form that is processed into the B24-, and B15-17 kDa products, a PDGF-B molecule was engineered with a flag epitope was fused to its C-terminus (PDGF-B-flag). Following transient transfection of HK293 cells with PDGF-Bflag, using an anti-flag mAb, Western blot analysis of cell lysates revealed that similarly to the wild-type form of PDGF-B, PDGF-B-flag is also processed in these cells. However, only the B35-and B24 kDa species were flag-immunoreactive ( Figure 1b, lane 2) , suggesting that the production of the B24 kDa product is generated by a single cleavage of the B35 kDa precursor, and that B15-17 kDa product requires a second processing step. The first cleavage is likely positioned immediately upstream of the N-terminus of the mature form of PDGF-B and the second one downstream of its C-terminus. The insertion of the flag sequence at the carboxyl-terminal (CT) end did not affect the PDGF-B biological activity, as demonstrated by the ability of the media derived from PDGF-B-flagtransfected HK293 cells to induce PDGF receptor tyrosine phosphorylation and [3H]methyl-thymidine incorporation in NIH/BALB-c 3T3 cells, as compared to PDGF-BB ligand (5 ng/ml) and media derived from wild-type PDGF-B-transfected HK293 cells (Figure 1c) .
Examination of the aa sequence of the PDGF-B chain precursor revealed a potential proprotein convertase recognition motif RGRR 81 located immediately upstream of the N-terminus of mature PDGF-B (Figure 1 ), suggesting that cleavage at this site of the B35 kDa proPDGF-B by a basic aa-specific PC would generate the B24 kDa product. In order to define the second ) completely abrogated the processing of proPDGF-B in these cells, as revealed by immunoblotting using PDGF-B (Figure 2 ). This is in accord with the implication of one or more member of the basic aa-specific PC in the cleavage of proPDGF-B at the RGRR 81 site. Interestingly, absence of cleavage at the RGRR 81 site virtually prevented the expected second C-terminal cleavage, suggesting that PC-directed processing may be a prerequisite for the second cleavage step.
In contrast to the N-terminal processing, cleavage of the wild-type PDGF-B was similar to that of its indicated that the C-terminal cleavage of PDGF-B is neither mediated by a basic aa-specific PC-like or SKI-1 activity (Seidah and Prat, 2002) , in order to occur, it must be preceded by cleavage of proPDGF-B at the N-terminal RGRR 81 k motif (Figure 2 ).
PCs and the processing of proPDGF-B
Four members of the proprotein convertase family namely, Furin, PACE4, PC5, and PC7 have been implicated in the processing of precursor molecules in cells lacking secretory granules, within a pathway known as the constitutive secretory pathway . To identify the basic aa-specific PCs involved in the processing of proPDGF-B at the N-terminal site, the cleavage of proPDGF-B was examined in vitro using a synthetic peptide containing the N-terminal cleavage site of proPDGF-B and in the Furin-deficient colon carcinoma cell line, LoVo-C5 cells (Figure 3 ) that express low levels of PACE4, PC5, and PC7 mRNAs (not shown).
To assess in vitro processing of PDGF-B by the PCs, we synthesized a 13-mer peptide (PDGF-B 73À83 : ( Figure 3b . The measurement of the kinetic parameters of this analysis revealed that PC5 was the most active enzyme in processing of proPDGF-B, followed by Furin, PC7, and then PACE4 (Figure 3b ).
To confirm the processing of proPDGF-B by these PCs in a cellular context, we analysed the cleavage of proPDGF-B in the LoVo-C5 cells. Following transient transfections of these cells with PDGF-B alone, using an anti-PDGF-B antibody (RDI, research diagnostics), immunoblotting analysis of cell lysates revealed that these cells are unable to efficiently process PDGF-B. Cotransfection of LoVo-C5 cells with PDGF-B and vectors encoding Furin, PACE4, PC5, PC7 or the convertase SKI-1, revealed that except for SKI-1, all the overexpressed PCs tested were able to process proPDGF-B into mature PDGF-B (B14-17 kDa) ( Figure 3c ). -antitrypsin (a1-PDX) and a2-macroglobulin-Furin (a2-MG-F) and the prosegments preproFurin (ppFurin), ppPACE4, ppPC5 and ppPC7. After transfection, the cell lysates were analysed for ProPDGF-B processing using PDGF-B antibody (UpState) In order to assess the efficiency of PC-inhibitors on proPDGF-B processing by PC-like endogenous convertases, we co-transfected HK293 cells with vectors encoding proPDGF-B and each of the PC-inhibitors, including the PC-prosegments (Zhong et al., 1999) , namely, the prosegments preproFurin (ppFurin), ppPACE4, ppPC5 and ppPC7 and the Furin-motif variants of a2-macroglobulin (a2-MG-F) and of the serpin a1-antitrypsin (a1-PDX) (Benjannet et al., 2001) . After transfection, the processing of PDGF-B was analysed in cell lysates by immunoblotting using a PDGF-B antibody. HK293 cells transfected with the vector encoding proPDGF-B revealed virtually complete processing proPDGF-B, as evidenced by the absence of proPDGF-B (Figure 3d ). This processing is significantly blocked by a1-PDX as well as by ppFurin, ppPC5, and ppPACE4.
Heterodimerization of proPDGF-B with either processed or unprocessed PDGF-A is favored
Like the B chain of PDGF-B, the A chain is also derived from a precursor protein that dimerizes in the ER to form proPDGF-AA or proPDGF-AB dimers. Using an anti-V5 antibody, immunoblotting analysis of the media of HK293 cells transfected with PDGF-A-V5 or its ARKA 86 mutant cDNA confirmed that proPDGF-A (B24 kDa) is processed at a single RRKR ) PDGF-B (Figure 4b ). Using a PDGF-AB antibody that recognizes the isoforms PDGF-AA, PDGF-AB and PDGF-BB, immunoblotting analysis of the cell lysates under nonreducing conditions revealed that of all the combinations tested, only the coexpression of A mut þ B resulted in the abrogation of the formation of the BB homodimer (Figure 4b , n), suggesting that heterodimerization of B-proA is favored over the homodimerization BB, in agreement with the known preference for the formation of AB versus BB dimers (Hammacher et al., 1988a) . In addition, the coexpression of A þ B mut showed the preferential formation of A-proB over the proBproB homodimer. The identities of A-containing complexes were confirmed by immunoblotting analysis of the cell lysates using anti-V5 antibody that detects the AA and AB forms (Figure 4c ). These data suggest the preference of the endoplasmic reticulum-localized heterodimerization over homodimerization (Ostman et al., 1992) , even when the A and/or B forms are not cleavable by the PCs.
Processing of proPDGF-B by Furin enhances secretion of its mature dimeric form
Previously, it was reported that, contrary to PDGF-A, the majority of the newly produced PDGF-B is retained at the cell surface, due to the presence of basic residues localized at the C-terminal end of the precursor within the segment aa 212-226 (LaRochelle et al., 1991) . Interestingly, this PDGF-B cell retention motif is localized just after the proposed second cleavage site of PDGF-B (ARPVT 190 ). To evaluate the importance of PCs in the secretion of PDGF-A and PDGF-B, HK293 cells were transfected with wild-type and mutated PDGF-A or PDGF-B. After transfection, and following pulse-labeling for 2 h with [ 35 S]Cys, the cell lysates and media were subjected to immunoprecipitation using an anti-PDGF-AB and resolved by SDS-PAGE under reducing conditions (Figure 5a ) and non-reducing conditions (Figure 5b ). The data show that overexpression of Furin results in an enhancement of the level of secreted wild type PDGF-A and PDGF-B homodimers, with a concomitant reduction in the levels of unprocessed precursors. Mutation of the PC-recognition motifs in both PDGFs did not significantly prevent secretion of the dimeric precursor forms.
Tissue localization of Furin and PDGF-B
To assess the possible coexpression of PDGF-B and at least one of its convertases Furin, we analysed in various tissues the expression of PDFG-B and Furin by RT-PCR and immunofluorescence. RT-PCR analysis revealed that in all mouse tissues analysed, the mRNA of PDGF-B and Furin are coexpressed. Highest expression of both mRNAs was observed in the liver, muscle, kidney, brain and heart, followed by the lung, colon, stomach and testis (Figure 6a ). Immunohistochemical analysis of various human tissues revealed the colocalization of PDGF-B and Furin in normal liver hepatocytes (Figure 6b) , and in lung carcinoma cells (Figure 6c ). However, although both proteins are detected in an aorta atheromatous lesion (Figure 6d ) and during skin wound healing (Figure 6e ), they do not seem to colocalize therein, suggesting that other members of the PC-family could process proPDGF-B in these tissues.
Discussion
ProPDGF-B is synthesized as an B31 kDa monomer that rapidly dimerizes in the ER via disulfide bridges to yield an B56-60 kDa proPDGF-BB dimer that transits to the Golgi complex where it undergoes proteolytic processing to produce a B40 kDa intermediate, which, after a second cleavage reaction results in a final mature B27 kDa product (Beckmann et al., 1988; Heldin and Westermark, 1999) . Following N-linked glycosylation, trimming and remodeling the B27 kDa PDGF-BB is converted to an B32 kDa mature form. The presence of a potential proprotein convertase consensus cleavage motif in the proPDGF-B sequence and the ubiquitous expression of the convertase Furin suggest this, or a related, convertase(s) candidate(s) proPDGF-BB processing enzyme(s). Mutagenesis studies revealed that the presence of an Arg or Lys at the P1 and/or the P4 positions of the PC-recognition motif (K/R)(X n )(K/R) is characteristic of the substrate specificity of the basic aaspecific PCs, including Furin . Indeed, expression of the mutated PDGF-B containing substitutions at the potential cleavage site (Figure 2 ). These findings emphasize the critical and stepwise processing of proPDGF-B that is initially processed by one or more members of the PC family.
In cell lines that naturally express both A-and B-chains, all three PDGF isoforms namely PDGF-AA, PDGF-BB and PDGF-AB are produced suggesting that the assembly of PDGF dimers is a random process (Hammacher et al., 1988a, b; Ostman et al., 1988 , Hoppe et al., 1990 , but that heterodimers are favored (Hammacher et al., 1988a) . This was supported by the use of cells transfected with the A-and B-chains that was shown to form all three PDGFs isoforms (Kaetzel et al., 1996) . In the present study, we further demonstrated that the heterodimer A-proB is favored over the homodimer proB-proB (Figure 4) . To identify the endogenous convertase(s) involved in proPDGF-B processing at the RGRR 81 k cleavage site, we took advantage of the Furin-deficient LoVo-C5 cells. We found that these cells are unable to process pro-PDGF-B and only the overexpression of Furin, PACE4, PC5 and PC7 restores their ability to process proPDGF-B into PDGF-B (Figure 3c ). This finding is in agreement with the in vitro digestions that indicated PC5 to be the most efficient enzyme, followed by Furin, PC7 and then by PACE4 (Figure 3a and b) . Using various PC-inhibitors, the processing of proPDGF-B was found to be blocked by a1-PDX, an engineered variant of a1-antitrypsin (Anderson et al., 1993; Benjannet et al., 1997) and by the inhibitory prosegments of PCs including pp-Furin, ppPC5 and ppPACE4 (Zhong et al., 1999; Benjannet et al., 2001 and Nour et al., 2003) .
In an effort to identify and/or characterize the protease that controls the C-terminal PDGF-B cleavage site, we introduced several Arg/Thr to Ala mutations in aas close to the aa sequence ARPVT 190 (ARPVT 190 RSPGGSQEQRAKTPQTRVTIR 211 TVRVRRP) that contain motifs somewhat reminiscent of either the basic aa-specific PC-like (RTVRVR) or SKI-1 (RPVT or RTVR) sites. The data demonstrated that PCs only process proPDGF-B at the RGRR 81 k site in HK293 cells (Figure 2) . Furthermore, the expression of SKI-1 in LoVo-C5 cells did not enhance processing (Figure 2) , nor was the C-terminal processing PDGF-B abrogated in SKI-1-deficient CHO cells (Pullikotil et al., 2004) (not shown). Since NARC-1/PCSK9 is not expressed in HK293 cells , the above results rule out the implication of any member of the PC-family in this C-terminal processing event. Similarly, using high concentrations of the general metalloproteinase inhibitor O-phenantholine failed to inhibit the C-terminal processing of PDGF-B (not shown). Although the nature of cognate C-terminal processing enzyme is still obscure, our data clearly demonstrate that the PC-mediated N-terminal processing of PDGF-B is a prerequisite for the C-terminal cleavage event, thereby regulating the maturation of PDGF-B, its retention at the cell surface and secretion into the medium.
Many growth factors are synthesized initially as precursors that are rapidly endoproteolytically processed Khatib et al., 2002) . Proteolytic cleavage of these precursors is an essential step in the formation of the biologically active form in both physiological and physio-pathological circumstances (Khatib et al., 2002) . In this study, we found that the PCs are required for the conversion of proPDGF-B to its mature PDGF-B dimeric form, and facilitate its secretion and/or attachment to the extracellular matrix. Thus, mature PDGF-B becomes more diffusible and may act on cells at some distance from the producer cell. Indeed, the presence of a basic sequence (aa 212-226) at the C-terminal end (proPDGF-B or its PC-generated intermediate form) mediates its interaction with various components of the extracellular matrix, including heparan sulfate, thought to be its major interactor (LaRochelle et al., 1991; Rolny et al., Figure 6 Coexpression of Furin and PDGF-B in tissues. The coexpression of PDGF-B and Furin were analysed in various normal tissues using RT-PCR and immunofluorescence analysis as described in detail in Materials and methods (a). RT-PCR analysis revealed that in all the mice tissues analysed, the mRNA of PDGF-B and Furin are coexpressed. Immunohistochemical analysis revealed that PDGF-B and Furin are co-expressed in human normal liver hepatocytes (b) and in lung carcinoma cells (c). Although furin and PDGF-B are expressed in an aorta atheromatous lesion (d) and during skin wound healing (e), they seem to be produce by different cells. No staining was observed in the negative controls. In hepatocytes and lung carcinoma cells, both, PDGF-B and Furin were found to be co-expressed (green arrow), suggesting the interaction between the two under autocrine manner. In the blood vessel (BV) of a skin wound and atheromatous aorta, myofibroblasts (green arrow) PDGF-B and Furin were found to be expressed by different cells, suggesting a potential paracrine interaction 2002). This would result in the retention of the unprocessed and/or PC-cleaved form of PDGF-B at the cell surface, to be released in a controllable manner by a second processing event (LaRochelle et al., 1991; Andersson et al., 1994; Rolny et al., 2002) . Conversely, several studies reported that deletion of the retention motif in PDGF-B leads to its increased secretion and accumulation in the cell culture media (LaRochelle et al., 1991; Andersson et al., 1994; Kaetzel et al., 1996) . In addition, the reduced secretion of PDGF-B was previously reported to limit the action range of PDGF-B in vivo, as suggested from experiments with transplanted keratinocytes expressing wild-type or retention motiftruncated PDGF-B into athymic mice (Eming et al., 1999) .
Like other members of the PDGF family, PDGF-B has been directly implicated in many physiological processes ranging from developmental events to wound healing, as well as in various diseases including vascular atheromas and cancers (Heldin and Westermark, 1999) . PDGF-B has been shown to promote diverse pleitropic effects on cellular metabolism. It stimulates aa transport and protein synthesis and an increase in cholesterol ester uptake and synthesis (Heldin and Westermark, 1999) . Thus, physiological levels of PDGF-B are necessary for tissue repair and maintenance of organ functions. Analysis of various tissues showed the coexpression of PDGF-B and Furin mRNAs, reinforcing the functional link between the two. Previously the expression of PDGFs and their receptors was reported to be crucial for normal tissue development, through both autocrine as well as paracrine actions (Bostrom et al., 1996) . Indeed, while mice deficient for PDGF-B die before birth, 50% of PDGF-A-deficient mice die before embryonic day 10 (E10) and the other half die postnatally (Mercola et al., 1990; Orr-Urtreger and Lonai, 1992; Bostrom et al., 1996; Ataliotis and Mercola, 1997; Heldin and Westermark, 1999) . Interestingly, Furin is expressed as early as E7 in embryos (Zheng et al., 1994) and the null allele of Furin is also lethal at E11, probably due to the accumulation of inactive protein precursor(s), of which the processing is crucial for the early stage of embryonic development (Roebroek et al., 1998) . In tissues of E7 embryos, the expression of Furin and PDGFs coincides with the expression of functional PDGF receptors. Thus, at E7, a striking temporal correlation in the expression of Furin to functional PDGF and PDGF receptors is deduced. These data reinforce the notion that the convertases may play a critical role in regulating the physiological function of PDGF-B in a paracrine and/or autocrine manner during embryonic development. On the other hand, over-expression of PDGF-B was linked to various diseases including cancer, pulmonary fibrosis and atherosclerosis (Nabel et al., 1993; Sundberg et al., 1997; Hoyle et al., 1999) . In the future, it will thus be interesting to explore the role of the PC-generated processing of proPDGF-B in various pathologies, such as cancer, where upregulation of one or more convertases were previously reported (Khatib et al., 2002; Bassi et al., 2003) .
Materials and methods
ProPDGF-B constructs cell transfections and culture
The human proPDGF-B cDNA was cloned into HindIII/XhoIdigested pcDNA3-zeo-flag vector (with a C-terminal flag-tag) to obtain the pcDNA3-zeo-PDGF-B-flag. Using the primers indicated in Table 1 , mutagenesis was carried out PCR to generate the N-terminal PDGF-B mutants R78A/R81A, and the C-terminal mutants R187A/T190A, R211A, R214A, R216A and R214/R216 (Table 1) . The mutated PDGF-B cDNA were re-cloned into the pcDNA3-zeo-flag and the sequences were verified by sequencing. The proPDGF-A cDNA was cloned into XhoI/BamHI-digested pIRES2-EGFP-V5 vector (Clontech, Palo Alto, CA, USA) to generate pIRES2-EGFP-PDGF-A-V5 (Siegfried et al., 2003b) . All the transfections were carried out using the Effectene transfection reagent (QIAGEN Inc., Mississauga, ON, Canada) as recommended by the manufacturer. The Furin-deficient LoVo-C5 human colon adenocarcinoma cells were transiently cotransfected with the pcDNA3-zeo-flag empty vectors, pcDNA3-zeo-flag containing wild-type PDGF-B cDNA, or with the pcDNA3-zeo-flag vector containing PDGF-B and pIRES2-EGFP vectors that express full-length indicated convertases. Human embryonic kidney (HK293) cells were transiently cotransfected with the pIRES2-EGFP-V5 empty vector, wild-type or mutant pcDNA3-zeo-PDGF-B-flag constructs or with the pcDNA3-zeo-PDGF-B-flag and pIRES2-EGFP that expresses PCs inhibitors including preproFurin (ppFurin), ppPACE4, ppPC5, ppPC7, a2-macroglobulin (Benjannet et al., 2001; Khatib et al., 2002; Siegfried et al., 2003b) . In several experiments HK293 cells were transiently transfected with pcDNA3-zeo-flag empty vector expressing either wildtype or mutated PDGF-B cDNAs or cotransfected with the PDGF-A and PDGF-B constructs. Cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS), 100 units/ml penicillin, 100 mg/ml streptomycin (Life Technologies, Inc., Burlington, ON, Canada).
Tyrosine phosphorylation and cell growth assays
Confluent fibroblast NIH BALB/c-3T3 cells were maintained in serum-free DMEM for 24 h and incubated for 10 min with PDGF-BB (5 ng/ml) (Sigma-Aldrich Ltd, Oakville, ON., Canada), media derived from PDGF-B or PDGF-Bflag-transfected HK293 cells and analysed for tyrosine phosphorylation in NIH BALB/c-3T3 cells, as described previously (Siegfried et al., 2003b) . The effect of the indicated media on cell NIH BALB/c-3T3 cells proliferation was monitored, as previously described elsewhere (Siegfried et al., 2003b) .
RT-PCR analysis
Total RNA was extracted using the Trizol reagent (Life Technologies, Inc.) and were reversed-transcribed in a 20-ml reaction mixture. The PCRs were performed in a buffer supplied by the manufacturer as previously described (Siegfried et al., 2003a) using the oligonucleotides 5 0 -CCTCGGCC TGTGACTAGAAG-3 0 and 5 0 -AAGGCTCCTGCACACTT GTT-3 0 for PDGF-B (444-bp product), 5 0 -GCAACACCTGG TGGTACAGA-3 0 and 5 0 -TCTGCGGAGTAGTCATGTG G-3 0 for Furin (400-bp product), and 5 0 -TGGAAATCCCATC ACCATCT-3 0 and 5 0 -GTCTTCTGGGTGGCAGTGAT-3 0 for GAPDH (520-bp product). The amplified PCR products were analysed on a 1.5% agarose gel.
Western blotting
After transfection, conditioned media were collected and cells were lysed in phosphate-buffered saline (PBS) containing 2% NP-40. Cell lysates and/or conditioned media were subjected to SDS-PAGE gels. The proteins were blotted onto nitrocellulose membranes. The primary antibodies anti-flag (Stratagene), anti-V5 (Invitrogene), anti-PDGF-B (RDI, Research Diagnostics Inc., Flanders NJ, USA), antiPDGF-AB that recognize the PDGF isoforms PDGF-AA, PDGF-BB and PDGF-AB (UpState) were revealed by horseradish peroxidase-conjugated secondary antibodies (Amersham, Baie d'Urfe´, QC, Canada) and enhanced chemiluminescence (ECL þ Plus, Amersham), according to the manufacturer's instructions.
Metabolic labeling and immunoprecipitation
Following transfection, cells were washed and were metabolically labeled for 2-3 h with 200 mCi/ml [ 35 S]Cys. Conditioned media were collected and cells lysed in buffer containing 150 mM NaCl, 50 mM Tris-HCl, pH 6.8, 0.5% Nonidet P-40, 0.5% and sodium deoxycholate (Roche Molecular Biochemicals). Cell lysates and conditioned media were subject to immunoprecipitation as previously described (Benjannet et al., 2001 ).
Peptide synthesis
A peptide 73 LESLARGRRkSLGSNH 2 85 (PDGF-B 73À85 ), containing the proposed processing site of proPDGF-B was synthesized by automated solid phase peptide syntheser using Fmoc chemistry (Pioneer model, PerSeptive Biosystems, Framingham, MA, USA) Siegfried et al., 2003a) . After purification of crude PDGF-B 73À85 by reversephase high-performance liquid chromatography (RP-HPLC) on a Rainin (Dynamax) instrument, the peptide purity and concentration was determined by quantitative aa analysis following 24 h hydrolysis in the presence of 5.7 N HCl in vacuo at 1101C on a Beckman autoanalyser model 6300 with postcolumn ninhydrin detection system. The identity of the purified peptide was confirmed by Matrix-Assisted LaserDesorption Time-of-Flight (MALDI-TOF) mass spectrometry (Voyager DE-pro, PerSeptive Biosystems Instrument).
In vitro digestions of the synthetic peptide PDGF-B
73À85 with PCs
The recombinant forms of Furin, PACE4, PC5 and PC7 were obtained from culture media of either somatomammotroph GH 4 C 1 or BSC-40 cells following infection of respective cDNAs with vaccinia viruses Siegfried et al., 2003a) . The collected media were purified through chromatography over an anion exchange column, as described earlier Siegfried et al., 2003a) . The peptide PDGF-B 73À85 (10 mM) was digested with the same amount of each of the recombinant PC (exhibiting a similar level of activity when measured against 100 mM of the general PC substrate pERTKR-MCA) Siegfried et al., 2003a) . The crude digest was subjected to Surface-Enhanced Laser Desorption Ionization (SELDI) ProteinChip array analysis (Ciphergen Biosystems Inc., Fremont, CA, USA). Each digest was spotted onto each array spot and incubated for 20 min at room temperature. After washing, 0.5 ml of saturated matrix solution (a-cyano-4-hydroxycinnamic acid was used in 50% acetonitrile and 0.5% aqueous trifluoroacetic acid) was applied on each spot and allowed to air-dry. Mass spectrometry analysis was performed in a PBS-II mass reader (Ciphergen Biosystems). Spectra were collected by averaging 80-100 laser shots with a laser intensity of 140 and 180 and a detector sensitivity of 8. Spectrum analysis was performed using the ProteinChip software version 3.2 (Ciphergen Biosystems).
Determination of the kinetic parameters V max and K m for in vitro digestion of PDGF-B 73À85 by PCs
The determination of kinetic parameters V max and K m for the cleavage of PDGF-B by Furin, PACE4, PC5, and PC7 was carried out by incubating various amounts of PDGF-B 73À85 with 10 ml of each PC (exhibiting a similar level of activity when measured against 100 mM of the general PC substrate pERTKR-MCA). Percent of PDGF-B 73À85 peptide cleaved at various time points of each digestion at 251C was quantitated by measuring peak area by RP-HPLC. The data collected were used to calculate V max and K m using Michealis-Menton kinetics based on Grafit software (Sigma-Aldrich, Oakville, Ontario, Canada) as described earlier Siegfried et al., 2003a) .
Immunohistochemical analysis
To analyse the co-expression of PDGF-B and Furin, 4 mm thick sections of formalin fixed and paraffin-embedded human liver, skin, atheromatous elastic artery, and lung carcinoma were examined for PDGF-B and Furin expression using an
